Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Tumor Biology
Published in: Tumor Biology 6/2016

01-06-2016 | Review

Rap2B GTPase: structure, functions, and regulation

Authors: Zhesi Zhu, Jiehui Di, Zheng Lu, Keyu Gao, Junnian Zheng

Published in: Tumor Biology | Issue 6/2016

Login to get access

Abstract

Rap2B GTPase, a member of Ras-related protein superfamily, was first discovered from a platelet cDNA library in the early 1990s. Since then, it has been reported to play an important role in regulating cellular processes including cytoskeletal organization, cell growth, and proliferation. It can be stimulated and suppressed by a wide range of external and internal inducers, circulating between GTP-bound active state and GDP-bound inactive state. Increasing focus on Ras signaling pathway reveals critical effects of Rap2B on tumorigenesis. In particular, Rap2B behaves in a p53-dependent manner in regulation of apoptosis and migration. Apart from being an oncogenic activator, Rap2B has been found to participate in many other physiological events via diverse downstream effectors. In this review, we present recent studies on the structure, regulation, and multiple biological functions of Rap2B, shedding light on its potential status in treatment of cancer as well as other diseases.
Literature
1.
2.
Wittchen ES, van Buul JD, Burridge K, Worthylake RA. Trading spaces: Rap, Rac, and Rho as architects of transendothelial migration. Curr Opin Hematol. 2005;12:14–21.PubMedCrossRef
3.
Sayyah J, Bartakova A, Nogal N, Quilliam LA, Stupack DG, Brown JH. The Ras-related protein, Rap1A, mediates thrombin-stimulated, integrin-dependent glioblastoma cell proliferation and tumor growth. J Biol Chem. 2014;289:17689–98.PubMedPubMedCentralCrossRef
4.
Nancy V, Wolthuis RM, de Tand MF, Janoueix-Lerosey I, Bos JL, de Gunzburg J. Identification and characterization of potential effector molecules of the Ras-related GTPase Rap2. J Biol Chem. 1999;274:8737–45.PubMedCrossRef
5.
Huang H, Di J, Qu D, Gao Z, Zhang Y, Zheng J. Role of Rap2 and its downstream effectors in tumorigenesis. Anticancer Agents Med Chem. 2015;15:1269–76.PubMedCrossRef
6.
Bigler D, Gioeli D, Conaway MR, Weber MJ, Theodorescu D. Rap2 regulates androgen sensitivity in human prostate cancer cells. Prostate. 2007;67:1590–9.PubMedCrossRef
7.
8.
Paganini S, Guidetti GF, Catricala S, Trionfini P, Panelli S, Balduini C, et al. Identification and biochemical characterization of Rap2C, a new member of the Rap family of small GTP-binding proteins. Biochimie. 2006;88:285–95.PubMedCrossRef
9.
Pizon V, Chardin P, Lerosey I, Olofsson B, Tavitian A. Human cDNAs rap1 and rap2 homologous to the Drosophila gene Dras3 encode proteins closely related to ras in the ‘effector’ region. Oncogene. 1988;3:201–4.PubMed
10.
Farrell FX, Ohmstede CA, Reep BR, Lapetina EG. cDNA sequence of a new ras-related gene (rap2b) isolated from human platelets with sequence homology to rap2. Nucleic Acids Res. 1990;18:4281.PubMedPubMedCentralCrossRef
11.
Wu JX, Zhang DG, Zheng JN, Pei DS. Rap2a is a novel target gene of p53 and regulates cancer cell migration and invasion. Cell Signal. 2015;27:1198–207.PubMedCrossRef
12.
Zhang X, He Y, Lee KH, Dubois W, Li Z, Wu X, et al. Rap2b, a novel p53 target, regulates p53-mediated pro-survival function. Cell Cycle. 2013;12:1279–91.PubMedPubMedCentralCrossRef
13.
Tang J, Di J, Cao H, Bai J, Zheng J. p53-mediated autophagic regulation: a prospective strategy for cancer therapy. Cancer Lett. 2015;363:101–7.PubMedCrossRef
14.
Prabakaran I, Grau JR, Lewis R, Fraker DL, Guvakova MA. Rap2A is upregulated in invasive cells dissected from follicular thyroid cancer. J Thyroid Res. 2011;2011:979840.PubMedPubMedCentralCrossRef
15.
Liu Y, Sun W, Zhang K, Zheng H, Ma Y, Lin D, et al. Identification of genes differentially expressed in human primary lung squamous cell carcinoma. Lung Cancer. 2007;56:307–17.PubMedCrossRef
16.
Di JH, Qu DB, Lu Z, Li LT, Cheng Q, Xin Y, et al. Rap2B promotes migration and invasion of human suprarenal epithelioma. Tumour Biol. 2014;35:9387–94.PubMedPubMedCentralCrossRef
17.
Farrell FX, Yamamoto K, Lapetina EG. Prenyl group identification of rap2 proteins: a ras superfamily member other than ras that is farnesylated. Biochem J. 1993;289:349–55.PubMedPubMedCentralCrossRef
18.
Canobbio I, Trionfini P, Guidetti GF, Balduini C, Torti M. Targeting of the small GTPase Rap2b, but not Rap1b, to lipid rafts is promoted by palmitoylation at Cys176 and Cys177 and is required for efficient protein activation in human platelets. Cell Signal. 2008;20:1662–70.PubMedCrossRef
19.
Maridonneau-Parini I, de Gunzburg J. Association of rap1 and rap2 proteins with the specific granules of human neutrophils. Translocation to the plasma membrane during cell activation. J Biol Chem. 1992;267:6396–402.PubMed
20.
Zhang Q, Chen J, Wu W, Yuan J, Cheng S, Wu Y. Expression of RAP2B in human lung cancer. Carcinogenesis Teratogenesis Mutagenesis. 2007;19:466–8.
21.
Di J, Huang H, Qu D, Tang J, Cao W, Lu Z, et al. Rap2B promotes proliferation, migration, and invasion of human breast cancer through calcium-related ERK1/2 signaling pathway. Sci Rep. 2015;5:12363.PubMedPubMedCentralCrossRef
22.
Fu G, Liu Y, Yuan J, Zheng H, Shi T, Lei W, et al. Identification and functional analysis of a novel candidate oncogene RAP2B in lung cancer. Zhongguo Fei Ai Za Zhi. 2009;12:273–6.PubMed
23.
Azuara D, Rodriguez-Moranta F, de Oca J, Soriano-Izquierdo A, Mora J, Guardiola J, et al. Novel methylation panel for the early detection of colorectal tumors in stool DNA. Clin Colorectal Cancer. 2010;9:168–76.PubMedCrossRef
24.
25.
Tahara T, Arisawa T. DNA methylation as a molecular biomarker in gastric cancer. Epigenomics. 2015;7:475–86.PubMedCrossRef
26.
Bock C, Paulsen M, Tierling S, Mikeska T, Lengauer T, Walter J. CpG island methylation in human lymphocytes is highly correlated with DNA sequence, repeats, and predicted DNA structure. PLoS Genet. 2006;2:e26.PubMedPubMedCentralCrossRef
27.
Liu F, Killian JK, Yang M, Walker RL, Hong JA, Zhang M, et al. Epigenomic alterations and gene expression profiles in respiratory epithelia exposed to cigarette smoke condensate. Oncogene. 2010;29:3650–64.PubMedCrossRef
28.
29.
Daura-Oller E, Cabre M, Montero MA, Paternain JL, Romeu A. Specific gene hypomethylation and cancer: new insights into coding region feature trends. Bioinformation. 2009;3:340–3.PubMedPubMedCentralCrossRef
30.
Zhang S, Zhou M, Jiang G, Gong C, Cui D, Luo L, et al. Expression and DNA methylation status of the Rap2b gene in human bronchial epithelial cells treated by cigarette smoke condensate. Inhal Toxicol. 2015;27:502–9.PubMedCrossRef
31.
32.
Mollinedo F, Perez-Sala D, Gajate C, Jimenez B, Rodriguez P, Lacal JC. Localization of rap1 and rap2 proteins in the gelatinase-containing granules of human neutrophils. FEBS Lett. 1993;326:209–14.PubMedCrossRef
33.
Greco F, Ciana A, Pietra D, Balduini C, Minetti G, Torti M. Rap2, but not Rap1 GTPase is expressed in human red blood cells and is involved in vesiculation. Biochim Biophys Acta. 2006;1763:330–5.PubMedCrossRef
34.
Torti M, Ramaschi G, Sinigaglia F, Lapetina EG, Balduini C. Glycoprotein IIb-IIIa and the translocation of Rap2B to the platelet cytoskeleton. Proc Natl Acad Sci U S A. 1994;91:4239–43.PubMedPubMedCentralCrossRef
35.
Lippi G, Montagnana M, Danese E, Favaloro EJ, Franchini M. Glycoprotein IIb/IIIa inhibitors: an update on the mechanism of action and use of functional testing methods to assess antiplatelet efficacy. Biomark Med. 2011;5:63–70.PubMedCrossRef
36.
Torti M, Bertoni A, Canobbio I, Sinigaglia F, Lapetina EG, Balduini C. Rap1b and Rap2b translocation to the cytoskeleton by von Willebrand factor involves Fcγii receptor-mediated protein tyrosine phosphorylation. J Biol Chem. 1999;274:13690–7.PubMedCrossRef
37.
38.
Selvaraj P, Fifadara N, Nagarajan S, Cimino A, Wang G. Functional regulation of human neutrophil Fc gamma receptors. Immunol Res. 2004;29:219–30.PubMedCrossRef
39.
Campa MJ, Farrell FX, Lapetina EG, Chang KJ. Microinjection of Rap2b protein or RNA induces rearrangement of pigment granules in Xenopus oocytes. Biochem J. 1993;292(Pt 1):231–6.PubMedPubMedCentralCrossRef
40.
41.
De Ferrari GV, Avila ME, Medina MA, Perez-Palma E, Bustos BI, Alarcon MA. Wnt/β-catenin signaling in Alzheimer’s disease. CNS Neurol Disord Drug Targets. 2014;13:745–54.PubMedCrossRef
42.
He X, Semenov M, Tamai K, Zeng X. LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. Development. 2004;131:1663–77.PubMedCrossRef
43.
Veeman MT, Axelrod JD, Moon RT. A second canon, functions and mechanisms of beta-catenin-independent Wnt signaling. Dev Cell. 2003;5:367–77.PubMedCrossRef
44.
Sugimura R, Li L. Noncanonical Wnt signaling in vertebrate development, stem cells, and diseases. Birth Defects Res C Embryo Today. 2010;90:243–56.PubMedCrossRef
45.
Marsden M, DeSimone DW. Regulation of cell polarity, radial intercalation and epiboly in Xenopus: novel roles for integrin and fibronectin. Development. 2001;128:3635–47.PubMed
46.
McLeod SJ, Shum AJ, Lee RL, Takei F, Gold MR. The Rap GTPases regulate integrin-mediated adhesion, cell spreading, actin polymerization, and Pyk2 tyrosine phosphorylation in B lymphocytes. J Biol Chem. 2004;279:12009–19.PubMedCrossRef
47.
48.
Mestre MB, Colombo MI. cAMP and EPAC are key players in the regulation of the signal transduction pathway involved in the alpha-hemolysin autophagic response. PLoS Pathog. 2012;8:e1002664.PubMedPubMedCentralCrossRef
49.
50.
Roscioni SS, Elzinga CR, Schmidt M. Epac: effectors and biological functions. Naunyn Schmiedebergs Arch Pharmacol. 2008;377:345–57.PubMedCrossRef
51.
Chalmeau J, Monina N, Shin J, Vieu C, Noireaux V. Alpha-hemolysin pore formation into a supported phospholipid bilayer using cell-free expression. Biochim Biophys Acta. 1808;2011:271–8.
52.
53.
Kobayashi S. Choose delicately and reuse adequately: the newly revealed process of autophagy. Biol Pharm Bull. 2015;38:1098–103.PubMedCrossRef
54.
Rubinsztein DC, Codogno P, Levine B. Autophagy modulation as a potential therapeutic target for diverse diseases. Nat Rev Drug Discov. 2012;11:709–30.PubMedPubMedCentralCrossRef
55.
Codogno P, Mehrpour M, Proikas-Cezanne T. Canonical and non-canonical autophagy: variations on a common theme of self-eating? Nat Rev Mol Cell Biol. 2012;13:7–12.
56.
Munson MJ, Allen GF, Toth R, Campbell DG, Lucocq JM, Ganley IG. mTOR activates the VPS34-UVRAG complex to regulate autolysosomal tubulation and cell survival. EMBO J. 2015;34:2272–90.PubMedPubMedCentralCrossRef
57.
Mestre MB, Fader CM, Sola C, Colombo MI. Alpha-hemolysin is required for the activation of the autophagic pathway in Staphylococcus aureus-infected cells. Autophagy. 2010;6:110–25.PubMedCrossRef
58.
59.
Campoy E, Colombo MI. Autophagy in intracellular bacterial infection. Biochim Biophys Acta. 2009;1793:1465–77.PubMedCrossRef
60.
Torti M, Ramaschi G, Sinigaglia F, Lapetina EG, Balduini C. Association of the low molecular weight GTP-binding protein rap2B with the cytoskeleton during platelet aggregation. Proc Natl Acad Sci U S A. 1993;90:7553–7.PubMedPubMedCentralCrossRef
61.
Di J, Huang H, Wang Y, Qu D, Tang J, Cheng Q, et al. p53 target gene Rap2B regulates the cytoskeleton and inhibits cell spreading. J Cancer Res Clin Oncol. 2015;141:1791–8.PubMedCrossRef
62.
Zhang Q, Duan L, Xu H, Yuan J, Wu W, Wu Y, et al. Effects of Rap2b gene on foci formation and wound-healing of NIH3T3 cells. Wei Sheng Yan Jiu. 2010;39:403–6.PubMed
63.
Itahana K, Mao H, Jin A, Itahana Y, Clegg HV, Lindstrom MS, et al. Targeted inactivation of Mdm2 ring finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation. Cancer Cell. 2007;12:355–66.PubMedCrossRef
64.
Di J, Zhang Y, Zheng J. Reactivation of p53 by inhibiting Mdm2 E3 ligase: a novel antitumor approach. Curr Cancer Drug Targets. 2011;11:987–94.PubMedCrossRef
65.
Zhang Q, Xing R, Xu H, Yuan J, Li C, Wu W, et al. Construction of eukaryotic expression vector of rap2b and its effects on pathway of nih3t3 cells. Cancer Res Prevention Treat. 2010;37:640–3.
66.
Zhu JJ, Qin Y, Zhao M, Van Aelst L, Malinow R. Ras and Rap control AMPA receptor trafficking during synaptic plasticity. Cell. 2002;110:443–55.PubMedCrossRef
67.
Ryu J, Futai K, Feliu M, Weinberg R, Sheng M. Constitutively active Rap2 transgenic mice display fewer dendritic spines, reduced extracellular signal-regulated kinase signaling, enhanced long-term depression, and impaired spatial learning and fear extinction. J Neurosci. 2008;28:8178–88.PubMedPubMedCentralCrossRef
68.
Zhu Y, Pak D, Qin Y, McCormack SG, Kim MJ, Baumgart JP, et al. Rap2-JNK removes synaptic AMPA receptors during depotentiation. Neuron. 2005;46:905–16.PubMedCrossRef
69.
Fu Z, Lee SH, Simonetta A, Hansen J, Sheng M, Pak DT. Differential roles of Rap1 and Rap2 small GTPases in neurite retraction and synapse elimination in hippocampal spiny neurons. J Neurochem. 2007;100:118–31.PubMedCrossRef
70.
Miertzschke M, Stanley P, Bunney TD, Rodrigues-Lima F, Hogg N, Katan M. Characterization of interactions of adapter protein RAPL/Nore1B with RAP GTPases and their role in T cell migration. J Biol Chem. 2007;282:30629–42.PubMedCrossRef
71.
72.
73.
Ohba Y, Mochizuki N, Matsuo K, Yamashita S, Nakaya M, Hashimoto Y, et al. Rap2 as a slowly responding molecular switch in the Rap1 signaling cascade. Mol Cell Biol. 2000;20:6074–83.PubMedPubMedCentralCrossRef
74.
Pak DT, Yang S, Rudolph-Correia S, Kim E, Sheng M. Regulation of dendritic spine morphology by SPAR, a PSD-95-associated RapGAP. Neuron. 2001;31:289–303.PubMedCrossRef
75.
Singh L, Gao Q, Kumar A, Gotoh T, Wazer DE, Band H, et al. The high-risk human papillomavirus type 16 E6 counters the GAP function of E6TP1 toward small Rap G proteins. J Virol. 2003;77:1614–20.PubMedPubMedCentralCrossRef
76.
Minato N, Hattori M. Spa-1 (Sipa1) and Rap signaling in leukemia and cancer metastasis. Cancer Sci. 2009;100:17–23.PubMedCrossRef
77.
Christian JL, Olson DJ, Moon RT. Xwnt-8 modifies the character of mesoderm induced by bFGF in isolated Xenopus ectoderm. EMBO J. 1992;11:33–41.PubMedPubMedCentral
78.
Baker JC, Beddington RS, Harland RM. Wnt signaling in Xenopus embryos inhibits bmp4 expression and activates neural development. Genes Dev. 1999;13:3149–59.PubMedPubMedCentralCrossRef
79.
Wessely O, Agius E, Oelgeschlager M, Pera EM, De Robertis EM. Neural induction in the absence of mesoderm: beta-catenin-dependent expression of secreted BMP antagonists at the blastula stage in Xenopus. Dev Biol. 2001;234:161–73.PubMedPubMedCentralCrossRef
80.
81.
Gloerich M, ten Klooster JP, Vliem MJ, Koorman T, Zwartkruis FJ, Clevers H, et al. Rap2A links intestinal cell polarity to brush border formation. Nat Cell Biol. 2012;14:793–801.PubMedCrossRef
82.
Greco F, Sinigaglia F, Balduini C, Torti M. Activation of the small GTPase Rap2B in agonist-stimulated human platelets. J Thromb Haemost. 2004;2:2223–30.PubMedCrossRef
83.
Woulfe D, Jiang H, Mortensen R, Yang J, Brass LF. Activation of Rap1B by G(i) family members in platelets. J Biol Chem. 2002;277:23382–90.PubMedCrossRef
84.
85.
Torti M, Lapetina EG. Structure and function of rap proteins in human platelets. Thromb Haemost. 1994;71:533–43.PubMed
86.
Keiper M, Stope MB, Szatkowski D, Bohm A, Tysack K, Vom Dorp F, et al. Epac- and Ca2+ -controlled activation of Ras and extracellular signal-regulated kinases by Gs-coupled receptors. J Biol Chem. 2004;279:46497–508.PubMedCrossRef
87.
Lova P, Paganini S, Hirsch E, Barberis L, Wymann M, Sinigaglia F, et al. A selective role for phosphatidylinositol 3,4,5-trisphosphate in the Gi-dependent activation of platelet Rap1B. J Biol Chem. 2003;278:131–8.PubMedCrossRef
88.
Song C, Hu CD, Masago M, Kariyai K, Yamawaki-Kataoka Y, Shibatohge M, et al. Regulation of a novel human phospholipase C, PLCepsilon, through membrane targeting by Ras. J Biol Chem. 2001;276:2752–7.PubMedCrossRef
89.
Schmidt M, Evellin S, Weernink PA, von Dorp F, Rehmann H, Lomasney JW, et al. A new phospholipase-C-calcium signalling pathway mediated by cyclic AMP and a Rap GTPase. Nat Cell Biol. 2001;3:1020–4.PubMedCrossRef
90.
Evellin S, Nolte J, Tysack K, vom Dorp F, Thiel M, Weernink PA, et al. Stimulation of phospholipase C-epsilon by the M3 muscarinic acetylcholine receptor mediated by cyclic AMP and the GTPase Rap2B. J Biol Chem. 2002;277:16805–13.PubMedCrossRef
91.
Stope MB, Vom Dorp F, Szatkowski D, Bohm A, Keiper M, Nolte J, et al. Rap2B-dependent stimulation of phospholipase C-epsilon by epidermal growth factor receptor mediated by c-Src phosphorylation of RasGRP3. Mol Cell Biol. 2004;24:4664–76.PubMedPubMedCentralCrossRef
92.
Gialeli C, Theocharis AD, Karamanos NK. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J. 2011;278:16–27.PubMedCrossRef
93.
Micalizzi DS, Farabaugh SM, Ford HL. Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia. 2010;15:117–34.PubMedPubMedCentralCrossRef
94.
Jung CH, Kim EM, Park JK, Hwang SG, Moon SK, Kim WJ, et al. Bmal1 suppresses cancer cell invasion by blocking the phosphoinositide 3-kinase-Akt-MMP-2 signaling pathway. Oncol Rep. 2013;29:2109–13.PubMedPubMedCentral
95.
Lu CY, Lai SC. Induction of matrix metalloproteinase-2 and -9 via Erk1/2-NF-kappaB pathway in human astroglia infected with Toxoplasma gondii. Acta Trop. 2013;127:14–20.PubMedCrossRef
96.
Bae IH, Park MJ, Yoon SH, Kang SW, Lee SS, Choi KM, et al. Bcl-w promotes gastric cancer cell invasion by inducing matrix metalloproteinase-2 expression via phosphoinositide 3-kinase, Akt, and Sp1. Cancer Res. 2006;66:4991–5.PubMedCrossRef
97.
Taira K, Umikawa M, Takei K, Myagmar BE, Shinzato M, Machida N, et al. The Traf2- and Nck-interacting kinase as a putative effector of Rap2 to regulate actin cytoskeleton. J Biol Chem. 2004;279:49488–96.PubMedCrossRef
98.
Machida N, Umikawa M, Takei K, Sakima N, Myagmar BE, Taira K, et al. Mitogen-activated protein kinase kinase kinase kinase 4 as a putative effector of Rap2 to activate the c-Jun N-terminal kinase. J Biol Chem. 2004;279:15711–4.PubMedCrossRef
99.
Myagmar BE, Umikawa M, Asato T, Taira K, Oshiro M, Hino A, et al. PARG1, a protein-tyrosine phosphatase-associated RhoGAP, as a putative Rap2 effector. Biochem Biophys Res Commun. 2005;329:1046–52.PubMedCrossRef
100.
Xie X, Liu H, Wang M, Ding F, Xiao H, Hu F, et al. miR-342-3p targets RAP2B to suppress proliferation and invasion of non-small cell lung cancer cells. Tumour Biol. 2015;36:5031–8.PubMedCrossRef
101.
102.
103.
Yook JI, Li XY, Ota I, Hu C, Kim HS, Kim NH, et al. A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells. Nat Cell Biol. 2006;8:1398–406.PubMedCrossRef
104.
Gilles C, Polette M, Mestdagt M, Nawrocki-Raby B, Ruggeri P, Birembaut P, et al. Transactivation of vimentin by beta-catenin in human breast cancer cells. Cancer Res. 2003;63:2658–64.PubMed
105.
Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 2006;25:9–34.PubMedCrossRef
106.
Anastas JN, Moon RT. Wnt signalling pathways as therapeutic targets in cancer. Nat Rev Cancer. 2013;13:11–26.PubMedCrossRef
107.
Iacobuzio-Donahue CA, Herman JM. Autophagy, p53, and pancreatic cancer. N Engl J Med. 2014;370:1352–3.PubMedCrossRef
Metadata
Title
Rap2B GTPase: structure, functions, and regulation
Authors
Zhesi Zhu
Jiehui Di
Zheng Lu
Keyu Gao
Junnian Zheng
Publication date
01-06-2016
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 6/2016
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-016-5033-y

Other articles of this Issue 6/2016

Tumor Biology 6/2016 Go to the issue

Original Article

RETRACTED ARTICLE: Overexpression of interleukins IL-17 and IL-8 with poor prognosis in colorectal cancer induces metastasis

Original Article

Reciprocal regulation of Hsa-miR-1 and long noncoding RNA MALAT1 promotes triple-negative breast cancer development

Original Article

A variant at a potentially functional microRNA-binding site in BRIP1 was associated with risk of squamous cell carcinoma of the head and neck

Original Article

KRAS mutations in pancreatic circulating tumor cells: a pilot study

Original Article

Human epididymis protein 4 expression positively correlated with miR-21 and served as a prognostic indicator in ovarian cancer

Original Article

Overexpression of ABCC3 promotes cell proliferation, drug resistance, and aerobic glycolysis and is associated with poor prognosis in urinary bladder cancer patients
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits